The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 25, 2020
Filed:
Jun. 01, 2017
Applicant:
Kalvista Pharmaceuticals Limited, Wiltshire, GB;
Inventors:
Haydn Beaton, Loughborough, GB;
Jonathan Yates Boxhall, Loughborough, GB;
David Malcolm Crowe, Reading, GB;
Assignee:
KALVISTA PHARMACEUTICALS LIMITED, Porton Down, Wiltshire, GB;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 401/10 (2006.01); A61P 27/02 (2006.01); A61K 9/00 (2006.01);
U.S. Cl.
CPC ...
C07D 401/10 (2013.01); A61K 9/0053 (2013.01); A61P 27/02 (2018.01); A61K 2121/00 (2013.01); C07B 2200/13 (2013.01);
Abstract
The invention provides new polymorphs of N-[(6-cyano-2-fluoro-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide, pharmaceutical compositions containing them and their use in therapy.
Beaton, Haydn. (2020). Polymorphs of n-[(6-cyano-2-fluoro)-3-methoxyphenyl)methyl]-3-(methoxymethyl)-1-({4-[(2-oxopyridin-1-yl)methyl]phenyl}methyl)pyrazole-4-carboxamide as kallikrein inhibitors (U.S. Patent No. 10752607). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10752607
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile